Literature DB >> 34431698

Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.

Delphyne Descamps1, Andressa Peres de Oliveira2, Lorène Gonnin1, Sarah Madrières1, Jenna Fix1, Carole Drajac1, Quentin Marquant1, Edwige Bouguyon1, Vincent Pietralunga1, Hidekatsu Iha3, Armando Morais Ventura2, Frédéric Tangy4, Pierre-Olivier Vidalain4,5, Jean-François Eléouët1, Marie Galloux1.   

Abstract

Respiratory syncytial virus (RSV) is the main cause of acute respiratory infections in young children and also has a major impact on the elderly and immunocompromised people. In the absence of a vaccine or efficient treatment, a better understanding of RSV interactions with the host antiviral response during infection is needed. Previous studies revealed that cytoplasmic inclusion bodies (IBs), where viral replication and transcription occur, could play a major role in the control of innate immunity during infection by recruiting cellular proteins involved in the host antiviral response. We recently showed that the morphogenesis of IBs relies on a liquid-liquid-phase separation mechanism depending on the interaction between viral nucleoprotein (N) and phosphoprotein (P). These scaffold proteins are expected to play a central role in the recruitment of cellular proteins to IBs. Here, we performed a yeast two-hybrid screen using RSV N protein as bait and identified the cellular protein TAX1BP1 as a potential partner of this viral protein. This interaction was validated by pulldown and immunoprecipitation assays. We showed that TAX1BP1 suppression has only a limited impact on RSV infection in cell cultures. However, RSV replication is decreased in TAX1BP1-deficient (TAX1BP1 knockout [TAX1BP1KO]) mice, whereas the production of inflammatory and antiviral cytokines is enhanced. In vitro infection of wild-type or TAX1BP1KO alveolar macrophages confirmed that the innate immune response to RSV infection is enhanced in the absence of TAX1BP1. Altogether, our results suggest that RSV could hijack TAX1BP1 to restrain the host immune response during infection. IMPORTANCE Respiratory syncytial virus (RSV), which is the leading cause of lower respiratory tract illness in infants, remains a medical problem in the absence of a vaccine or efficient treatment. This virus is also recognized as a main pathogen in the elderly and immunocompromised people, and the occurrence of coinfections (with other respiratory viruses and bacteria) amplifies the risks of developing respiratory distress. In this context, a better understanding of the pathogenesis associated with viral respiratory infections, which depends on both viral replication and the host immune response, is needed. The present study reveals that the cellular protein TAX1BP1, which interacts with the RSV nucleoprotein N, participates in the control of the innate immune response during RSV infection, suggesting that the N-TAX1BP1 interaction represents a new target for the development of antivirals.

Entities:  

Keywords:  RSV; TAX1BP1; innate immunity; interferons; lung; nucleoprotein; yeast two-hybrid screening

Mesh:

Substances:

Year:  2021        PMID: 34431698      PMCID: PMC8549506          DOI: 10.1128/JVI.00912-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  80 in total

1.  Interactome networks between the human respiratory syncytial virus (HRSV), the human metapneumovirus (ΗMPV), and their host: In silico investigation and comparative functional enrichment analysis.

Authors:  Erasmia Rouka; Chrissi Hatzoglou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Microb Pathog       Date:  2020-01-25       Impact factor: 3.738

2.  Production of interferon in respiratory syncytial virus bronchiolitis.

Authors:  D Isaacs
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

3.  The kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1.

Authors:  Noula Shembade; Rajeshree Pujari; Nicole S Harhaj; Derek W Abbott; Edward W Harhaj
Journal:  Nat Immunol       Date:  2011-07-17       Impact factor: 25.606

4.  Severity of respiratory syncytial virus infection is related to virus strain.

Authors:  E E Walsh; K M McConnochie; C E Long; C B Hall
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

5.  Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter.

Authors:  U J Buchholz; S Finke; K K Conzelmann
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

6.  Autophagy receptors link myosin VI to autophagosomes to mediate Tom1-dependent autophagosome maturation and fusion with the lysosome.

Authors:  David A Tumbarello; Bennett J Waxse; Susan D Arden; Nicholas A Bright; John Kendrick-Jones; Folma Buss
Journal:  Nat Cell Biol       Date:  2012-09-30       Impact factor: 28.824

7.  Downregulation of A20 Expression Increases the Immune Response and Apoptosis and Reduces Virus Production in Cells Infected by the Human Respiratory Syncytial Virus.

Authors:  María Martín-Vicente; Rubén González-Sanz; Isabel Cuesta; Sara Monzón; Salvador Resino; Isidoro Martínez
Journal:  Vaccines (Basel)       Date:  2020-02-24

8.  Visualizing the replication of respiratory syncytial virus in cells and in living mice.

Authors:  Marie-Anne Rameix-Welti; Ronan Le Goffic; Pierre-Louis Hervé; Julien Sourimant; Aude Rémot; Sabine Riffault; Qin Yu; Marie Galloux; Elyanne Gault; Jean-François Eléouët
Journal:  Nat Commun       Date:  2014-10-03       Impact factor: 14.919

9.  Regulation of B cell differentiation by the ubiquitin-binding protein TAX1BP1.

Authors:  Nobuko Matsushita; Midori Suzuki; Emi Ikebe; Shun Nagashima; Ryoko Inatome; Kenichi Asano; Masato Tanaka; Masayuki Matsushita; Eisaku Kondo; Hidekatsu Iha; Shigeru Yanagi
Journal:  Sci Rep       Date:  2016-08-12       Impact factor: 4.379

10.  Alveolar Macrophages Can Control Respiratory Syncytial Virus Infection in the Absence of Type I Interferons.

Authors:  Spyridon Makris; Monika Bajorek; Fiona J Culley; Michelle Goritzka; Cecilia Johansson
Journal:  J Innate Immun       Date:  2016-07-16       Impact factor: 7.349

View more
  2 in total

Review 1.  Early innate immune response triggered by the human respiratory syncytial virus and its regulation by ubiquitination/deubiquitination processes.

Authors:  Salvador Resino; Isidoro Martínez; María Martín-Vicente
Journal:  J Biomed Sci       Date:  2022-02-13       Impact factor: 8.410

Review 2.  How RSV Proteins Join Forces to Overcome the Host Innate Immune Response.

Authors:  Tessa Van Royen; Iebe Rossey; Koen Sedeyn; Bert Schepens; Xavier Saelens
Journal:  Viruses       Date:  2022-02-17       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.